Hester Biosciences Limited — Board Meeting, 01-08-2025: Outcome of Board Meeting

Hester Biosciences' Board has approved the financial results for the quarter ended June 30, 2025. Consolidated revenue grew to ₹84.11 Cr (from ₹82.27 Cr YoY), with net profit surging 131% to ₹17.30 Cr (from ₹7.49 Cr). This profit jump was primarily due to a strong turnaround at Hester Africa, which posted a ₹5.50 Cr profit vs. a ₹5.00 Cr loss last year. While Animal Healthcare sales dipped temporarily due to delayed government programs, the company is focused on new product launches, diversification, and leveraging its African operations for future growth. #HesterBiosciences